If this Newsletter does not display properly click here to view it online.
FinData
Weekly Newsletter
for week ending 27/09/2016
Top 5 NZX Trades This Week
CodeWk OpenWk HighWk LowWk LastWk VolumeWk Change
AIA6.7007.6507.2107.1201,651,8040.4205.90%
CNU4.2004.6404.0503.7401,249,3570.46012.30%
SPK3.7003.9203.7603.5703,356,0530.1303.64%
TME5.4105.6105.3505.6301,722,8180.2203.91%
ATM2.0102.0501.8701.8502,203,1890.1608.65%
NZSX 50
NZSX 50 Index
ASX ALL ORDS
ASX All Ordinaries Index
NZD/USD
Foreign Exchange NZD/USD
DOW JONES
Dow Jones Index
NASDAQ
NASDAQ Index
FTSE 100
FTSE 100 Index
This Weeks Top Stories
Northwest Bancshares Inc versus United Community Financial Corp. Head to Head ...
22 Sep 2016 02:26 CML News
On a fundamental basis, we are looking at two exceptionally strong companies with star ratings near the top, so the head-to-head comparison will rely on a deep dive into specific metric comparisons.  more...
what are Analysts report about: Kinder Morgan, Inc. (NYSE:KMI)
20 Sep 2016 03:22 News Oracle
Kinder Morgan, Inc. (NYSE:KMI) reported its last earnings on Oct 19 AMC (BMO = before market open, AMC= after market close).  more...
Zacks Industry Outlook Highlights: NRG Energy, SunPower, First Solar ...
21 Sep 2016 02:37 Yahoo Finance
Solar and wind energy got a major boost from the environmental tax credit extension that came as part of the $1.15 trillion federal spending bill, which also lifted a 40-year ban on exporting American crude oil.  more...
Projected Revenue for Valeant in 2017
20 Sep 2016 04:52 Market Realist
By investing in the VanEck Vectors Pharmaceutical ETF (PPH), you would gain a 2.3% exposure to high-risk Valeant. Along with Valeant, the fund has Merck & Co.  more...
Rexahn Pharmaceuticals Inc (NYSEMKT:RNN) Is A Catalyst Driven Growth Play
20 Sep 2016 16:30 Street Register
There's the potential for dilution on the back of the shares issued, but they also generally precede a growth event, with the capital raised used to fund the event in question. Rexahn juts kicked off an early stage trial in one of its lead pipeline ...  more...
Home| News| Markets| My FinData| Portfolio| Contact
Site Map| Advertise Online With Us| Terms of Use| Privacy Policy| About FinData| Feedback
This email was sent to the following address: [CustomerEmail]
Why did I receive this email? [Source]
If you do not want to receive future Weekly Newsletter emails from findata.co.nz, click HERE

© FinData Limited 2008. All the material on this page has the protection of international copyright. All rights reserved.
blank